Confidence starts with the right data

Specialized bioanalytical CRO services, all under one roof

We offer full-spectrum LC-MS bioanalytical services that support timely, informed study decisions. From flexible non-regulated research to fully compliant clinical analysis, Veloxity Labs delivers high-quality data you can rely on — precisely when you need it.

LC-MS bioanalysis

Core services that power confident decisions

At Veloxity, our bioanalytical services are designed for speed, precision and flexibility. Whether you’re optimizing leads to support GLP studies or generating GCP-compliant clinical data, our integrated approach ensures consistency and quality at every step.

Capabilities include:

  • LC-MS bioanalysis
  • Method development and validation (GLP/GCP, ICH M10)
  • Analysis of samples from dried blood spot (DBS), Tasso, Mitra and other patient-centric devices
  • Biomarker analysis via LC-MS
  • Plasma protein binding
  • Whole blood to plasma partitioning
  • Integrated PK/TK analysis & reporting
  • Audit-readiness (GLP/GCP & ICH M10 compliant)
Our Bioanalytical Services
Drug Development Lifecycle
Early discovery to late-stage clinical

Support across all development phases

We support the full drug development lifecycle, helping teams generate decision-driving data at every step.

  • Discovery and early development
  • Lead optimization
  • Exploratory toxicology (e.g., dose-range finding, PK/TK profiling)
  • Pre-IND and IND-enabling studies
  • Clinical and post-approval programs
Industry expertise across sectors

Built for biotech, animal health and beyond

Our flexible, responsive model serves a wide range of sponsor types, including, but not limited to:

  • Biotech & pharma
  • Animal health
  • Emerging therapeutics
Bioanalytical Services
Therapeutic Areas
Therapeutic areas we work in

Expertise where it matters most

We specialize in complex and fast-moving therapeutic areas where data integrity and turnaround speed are critical.

  • Rare diseases
  • Cell & gene therapy (CGT)
  • Oncology
  • Metabolic disorders
  • and others
Matrix flexibility to match your program

Bioanalysis across a full range of sample types

Whether you’re working with traditional or challenging matrices, we have the validated processes to support your protocol.

  • Plasma/serum
  • Tissue
  • Whole blood
  • Dried blood
  • Cerebrospinal fluid (CSF)
  • Urine
Bioanalysis Samples Type
Overcoming Challenges in Medical Device Studies
Report

Pushing the Limits of Bioanalysis

Overcoming Selectivity Challenges in Medical Device Studies

In this report, Veloxity Labs details how we overcame critical selectivity challenges during a medical device study requiring ultra-sensitive bioanalysis in human plasma. By developing and validating a method with a 30 pg/mL LLOQ — while navigating unexpected interference — we optimized sample prep, chromatography and mobile phases to reduce analysis time by 70%. The result: a robust, cost-effective solution ready for clinical development. Download the full report to see how Veloxity’s expertise in bioanalytical method development supports success in pharma and biotech.